^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    OBI-3424

    i
    Company:
    Ascentawits Pharma, OBI Pharma
    Drug class:
    Alkylating agent
    Related drugs:
    Apply
    Study to Test AKR1C3-Activated Prodrug OBI-3424 (OBI-3424) in Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) (NCT04315324)
    Phase 2
    SWOG Cancer Research Network
    Recruiting
    Last update posted :
    02/09/2024
    Initiation :
    02/08/2021
    Primary completion :
    08/01/2026
    Completion :
    08/01/2027
    AKR1C3
    |
    AKR1C3 expression
    |
    OBI-3424